• Media type: E-Article
  • Title: Salivary IL-6 Concentration Is Associated with Frailty Syndrome in Older Individuals
  • Contributor: Gómez-Rubio, Pablo; Trapero, Isabel; Cauli, Omar; Buigues, Cristina
  • imprint: MDPI AG, 2022
  • Published in: Diagnostics
  • Language: English
  • DOI: 10.3390/diagnostics12010117
  • ISSN: 2075-4418
  • Keywords: Clinical Biochemistry
  • Origination:
  • Footnote:
  • Description: <jats:p>Background: One of the physiological changes that is most closely associated with frailty is the increase in pro-inflammatory cytokines, and IL-6 in particular. Most studies have demonstrated this association using blood samples. We analyzed the relationship between frailty syndrome, individual frailty criteria, and IL-6 levels obtained by saliva tests. Methods: A cross-sectional pilot study was performed among women institutionalized in nursing homes. Frailty was defined as having three or more of the following components: low lean mass, weakness, self-reported exhaustion, low activity level, and slow walking speed; prefrailty was defined as having one or two of those components. Results: There was a significant and positive correlation between the frailty score and salivary IL-6 concentration. Regarding the associations between IL-6 and individual dichotomized frailty criteria, there were significant differences in salivary IL-6 concentration in two frailty criteria: weight loss (p = 0.002) and low physical activity (p = 0.007). Receiver operating characteristic curve analysis showed that IL-6 concentration significantly (p &lt; 0.05) (although moderately) discriminated patients that progressed in the frailty syndrome (the area under the curve value was 0.697 with 95% CI 0.566–0.827). Conclusions: Salivary IL-6 concentration can be used as potential biomarker of frailty syndrome and as a tool to monitor the effects of interventions in frail individuals.</jats:p>
  • Access State: Open Access